FDA Drug Application (203021) for NEVIRAPINE by APOTEX INC

Back to FDA Applications sponsored by APOTEX INC

Application Number203021
Product Number001
FormTABLET;ORAL
Dosage200MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameNEVIRAPINE
Active IngredientNEVIRAPINE

Active IngredientCount
List of drugs with Active Ingredient NEVIRAPINE17


Back to FDA Applications sponsored by APOTEX INC